NewsRx

Search our medical news database

Drug Law Weekly

Susan Hasty, Publisher

Table of Contents . . . November 1st, 2005

Non-Subscriber - Summaries Only

Related Areas: Other Issues in Drug Law Weekly | Other Publications

Acuity Medical - Electrical stimulation device treats age-related macular degeneration

Aditus Medical - Electroporation-focused company expands its intellectual property portfolio

Blue Cross and Blue Shield of North Carolina - Blue Cross and Blue Shield of North Carolina to offer two Medicare prescription drug plans

Brown University, Providence - Hepatitis B and C virus infections flourish among reincarcerated females

Cygnus, Inc. - Cynus announces settlement of Ortho-McNeil arbitration over sale of drug-delivery business

Dragon Pharmaceutical, Inc. - Canadian pharma appoints Peter Mak, Heinz Frey, and Jin Li as independent directors

GeoPharma, Inc. - Court dismisses class action litigation relating to Mucotrol

Harvard Medical School - Medicare elimination of essential drugs will affect the elderly

Intranasal Therapeutics, Inc. - U.S. patent approval granted for multiple drug dose delivery device

M.D. Anderson Cancer Center - The origin of regulatory T cells that "police" and protect the body is revealed

Medicare - InStil Health approved to offer Medicare prescription drug plans in South Carolina, Georgia

Oncolytics Biotech Inc. - Biotech company issued Canadian patent for cellular proliferative disorders

Oxxon Therapeutics, Inc. - New patents covering PrimeBoost platform and immunotherapy products announced

PacifiCare Health Systems Inc. - Health plan enters agreement with AAA Auto Club South to market Part D plans

Research Australia - Recruitment for ovarian cancer vaccine clinical trial complete

A.P. Pharma, Inc. - Clinical endpoints achieved in phase II trial of anti-nausea drug

Abbott - Humira receives U.S. Food and Drug Administration approval for treatment of psoriatic arthritis

Acadia Pharmaceuticals, Inc. - Milestone earned on advancement of neuropathic pain clinical program

Accera, Inc. - A high fat, low carbohydrate diet improves Alzheimer disease in mice

ActivBiotics, Inc. - Phase III trial to be initiated for peripheral arterial disease drug

Adnan Menderes University, Aydin - DNA flow cytometry aids detection of malignant transformation in gastric lesions

Advance Nanotech, Inc. - Nanotechnology device funded to detect Avian influenza

Affymetrix, Inc. - Automated target preparation, microarray processing system launched

Akita University - Treatment with metformin and insulin does not affect adiponectin levels

Albany Medical College - Review of current treatment modalities predicts new intradiscal therapies are forthcoming

Altus Pharmaceuticals, Inc. - Positive data reported from phase I study of ALTU-238 for gastrointestinal, metabolic diseases

American Academy of Orthopedic Surgeons - Aging athletes require tailored exercise regimen to avoid overuse injuries

American Scientific Resources - Manufacturing begins for line of nutritional supplements designed for heart health

Arginox Pharmaceuticals - European and U.S. orphan drug designation granted for cardiogenic shock medication

Astellas Pharma, Inc. - Astellas and MerLion Pharmaceuticals announce new drug discovery agreement

Atrium Medical Corp. - Licensing deal signed for use of TAFA93 and ISA247 with medical devices

Avalon Pharmaceuticals, Inc. - Phase I trial to be initiated for AVN944 to treat hematological malignancies

BSD Medical Corp. - New breakthroughs in treating breast, cervical cancer discussed at radiation conference

Beijing Institute of Pharmacology and Toxicology - Reports add new data to respiratory syncytial virus research

Beth Israel Deaconess Medical Center, Boston - Novel treatments for metastatic alveolar soft part sarcoma are in need

BioDelivery Sciences International, Inc. - Drug delivery firm closes public offering of 4.4M shares

BioPlan Associates - Biopharmaceutical manufacturing capacity to increase 48% by 2010

Bioenvision - Interim results in phase II trial of Virostat show the drug is active against hepatitis C

Biogen Idec Inc. - Cancer drug maker names Naseem Amin as senior VP, business development

Bioheart, Inc. - Stem cell therapy company raises $19M in Series D round

Biomira, Inc. - Timetable changed for BLP25 liposome vaccine phase III trial

Brigham & Women's Hospital, Boston - Very early benefits of statin therapy may be correlated with CRP reductions

California Institute of Technology - Researcher receives $3.6 million to start Nanosystems Biology Cancer Center

California State University of Northridge - Researchers offer treatment of psychosocial challenges for women with gynecological cancer

CancerVax Corp. - Discontinuation of Canvaxin trials leads to layoffs

Carl Zeiss Meditec, Inc. - Optical coherence tomography system launched for the anterior segment

Cedars-Sinai Medical Center, Los Angeles - Infertility researchers identify one gene's critical role in the human embryo implantation process

Center of Experimental Medicine, Caracas - Speedy intervention urged to address vitamin B12 and folic acid deficiency in Venezuela

Centre for Clinical Pharmacology and Therapeutics - Mechanism of action of aspirin discovered, wins Aspirin Award

ChemGenex Pharmaceuticals, Ltd. - New phase II trial of Ceflatonin in Gleevec-resistant CML patients begins

Cleveland Clinic Foundation - New findings in the area of apoptosis described

Codexis, Inc. - Pfizer collaboration advances ahead of schedule

Columbia University - Cost-effectiveness of anterior cervical discectomy and fusion clarified

Columbia University - Use of bivalirudin to support SES implantation results in low rates of adverse events

Columbia University Medical Center - Black women with early-stage breast cancer are less likely to receive full course of chemotherapy

Complementary & Alternative Medicine - Alternative touch therapies may relax heart patients

CytRx Corp. - FDA grants fast track designation for arimoclomol in ALS

Cytori Therapeutics, Inc. - Data: Human adipose-derived adult stem cells have potential to differentiate into spinal disc

Dakar Fann National Hospital Center -  E. coli from AIDS patients in Senegal has low cotrimoxazole susceptibility

Dalhousie University - Protein-mediated membrane fusion machine reconstituted

Diagnostic Center of Ayios Therissos - Helical CT cholangiography provides valuable, exclusive data on bile activity

Diomed Holdings, Inc. - EVLT maker completes $10 million equity financing

Drexel University - Researchers' findings advance childhood obesity research

Drexel University, Philadelphia - Adriamycin delayed gross metastases from osteosarcoma

Dublin City University - Antibody 5C3 recognizes heteropolymer of cytokeratin 9

Duke University Medical Center, Durham - Study finds exercise amount is more important than the intensity

Emory University, Atlanta - Recombinant proteins can inhibit NF-kappa B activation

Epilepsy Foundation - Actions suggested to help reduce birth defects caused by mothers' use of anticonvulsants

Guidant Corp. - U.S. Food & Drug Administration approves new implantable defibrillator system

Thermage, Inc. - U.S. FDA approves IDE to study upper arm radiofrequency cosmetic procedure

U.S. Centers for Disease Control & Prevention - Prevalence of spina bifida and anencephaly declining in U.S. minorities

U.S. Department of Health and Human Services - U.S. NIAID and MedImmune join forces to develop potential pandemic influenza vaccines

U.S. Food & Drug Administration - Greater standardization of ultrasound backscatter measurement methods needed

U.S. Food & Drug Administration - Radiation plus IL-13 receptor-targeted cytotoxin kill glioblastoma cells

U.S. Food & Drug Administration - Russian ethnomedicinal plants more cytotoxic than established therapies

University of Kansas - Immunization with Japanese encephalitis vaccine beneficial to those at risk for West Nile

University of Wisconsin - Flu virus reported to resist drug envisioned for pandemic

Viron Therapeutics Inc. - Phase 2 trial of anti-inflammatory for acute coronary syndromes initiated

Return to Top of Page

NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook